Jiangsu Apon Medical Technology Co Ltd Class A (300753) — Capital Reinvestment Ratio
Jiangsu Apon Medical Technology Co Ltd Class A (300753) has a Capital Reinvestment Ratio of 0.11x as of December 2024, meaning it reinvests 0% of its operating cash flow (CN¥49.02 Million) in capital expenditures (CN¥5.48 Million). See Jiangsu Apon Medical Technology Co Ltd C (300753) net asset quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Jiangsu Apon Medical Technology Co Ltd Class A Capital Reinvestment Ratio (2014–2024)
This chart tracks Jiangsu Apon Medical Technology Co Ltd Class A's Capital Reinvestment Ratio across 9 annual periods. Check 300753 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Jiangsu Apon Medical Technology Co Ltd Class A (2014–2024)
Year-by-year Capital Reinvestment Ratio for Jiangsu Apon Medical Technology Co Ltd Class A from 2014 to 2024. For live market cap and broader valuation context, see 300753 market cap.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.65x | CN¥15.68 Million | CN¥10.23 Million | ▼ -69.9% |
| 2021 | 2.17x | CN¥18.29 Million | CN¥39.60 Million | ▲ +406.5% |
| 2020 | 0.43x | CN¥83.34 Million | CN¥35.64 Million | ▼ -43.1% |
| 2019 | 0.75x | CN¥77.59 Million | CN¥58.33 Million | ▼ -4.6% |
| 2018 | 0.79x | CN¥78.13 Million | CN¥61.59 Million | ▲ +237.5% |
| 2017 | 0.23x | CN¥67.08 Million | CN¥15.66 Million | ▲ +229.1% |
| 2016 | 0.07x | CN¥60.97 Million | CN¥4.33 Million | ▼ -12.8% |
| 2015 | 0.08x | CN¥38.08 Million | CN¥3.10 Million | ▲ +2.4% |
| 2014 | 0.08x | CN¥33.49 Million | CN¥2.66 Million | — |